Učitavanje...
Effect of Trastuzumab among HER2-Positive Breast Cancer Patients that Achieved Pathologic Complete Response after Neoadjuvant Chemotherapy
BACKGROUND: We sought to investigate the incremental benefit of trastuzumab in patients with HER2-positive breast cancer who achieved a pathologic complete response (pCR) after neoadjuvant chemotherapy (NACT). METHODS: The data of HER2-positive invasive breast cancer patients treated with NACT and a...
Spremljeno u:
| Izdano u: | Breast Care (Basel) |
|---|---|
| Glavni autori: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
S. Karger AG
2019
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6940431/ https://ncbi.nlm.nih.gov/pubmed/31933585 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000495186 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|